WO2002061037B1 - Administration d'une sequence d'acides amines a un animal femelle - Google Patents

Administration d'une sequence d'acides amines a un animal femelle

Info

Publication number
WO2002061037B1
WO2002061037B1 PCT/US2001/048726 US0148726W WO02061037B1 WO 2002061037 B1 WO2002061037 B1 WO 2002061037B1 US 0148726 W US0148726 W US 0148726W WO 02061037 B1 WO02061037 B1 WO 02061037B1
Authority
WO
WIPO (PCT)
Prior art keywords
vector
animal
female
cells
offspring
Prior art date
Application number
PCT/US2001/048726
Other languages
English (en)
Other versions
WO2002061037A2 (fr
WO2002061037A3 (fr
Inventor
Robert J Schwartz
Robert H Carpenter
Ruxandra Draghia-Akli
Douglas R Kern
Roy G Smith
Original Assignee
Baylor College Medicine
Advisys Inc
Robert J Schwartz
Robert H Carpenter
Ruxandra Draghia-Akli
Douglas R Kern
Roy G Smith
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine, Advisys Inc, Robert J Schwartz, Robert H Carpenter, Ruxandra Draghia-Akli, Douglas R Kern, Roy G Smith filed Critical Baylor College Medicine
Priority to KR10-2003-7007872A priority Critical patent/KR20040039187A/ko
Priority to CA2430921A priority patent/CA2430921C/fr
Priority to MXPA03005236A priority patent/MXPA03005236A/es
Priority to EP01997073A priority patent/EP1364004A4/fr
Priority to AU2002248194A priority patent/AU2002248194B2/en
Priority to BR0116472-4A priority patent/BR0116472A/pt
Publication of WO2002061037A2 publication Critical patent/WO2002061037A2/fr
Publication of WO2002061037A3 publication Critical patent/WO2002061037A3/fr
Publication of WO2002061037B1 publication Critical patent/WO2002061037B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0271—Chimeric animals, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth-hormone releasing factors (GH-RF) (Somatoliberin)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Abstract

La croissance est améliorée au moyen d'une technique d'amélioration du potentiel de la croissance, laquelle technique consiste à administrer une séquence d'acides aminés, telle que GHRH ou un analogue, à un animal femelle, de préférence par administration par voie parentérale. Les porcelets nés de truies auxquelles on a injecté un ADN codant pour GHRH, sont plus gros. Ces effets sont démontrés lors de gestations ultérieures sans administration(s) supplémentaire(s) du vecteur.
PCT/US2001/048726 2000-12-12 2001-12-12 Administration d'une sequence d'acides amines a un animal femelle WO2002061037A2 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
KR10-2003-7007872A KR20040039187A (ko) 2000-12-12 2001-12-12 암컷 동물에 핵산 서열의 투여
CA2430921A CA2430921C (fr) 2000-12-12 2001-12-12 Utilisation d'un vecteur codant pour un peptide de ghrh destine a ameliorer la croissance dans de multiples portees de la progeniture d'animaux femelles
MXPA03005236A MXPA03005236A (es) 2000-12-12 2001-12-12 Administracion de secuencia de acido nucleico a un animal hembra para mejorar el crecimiento en la progenie.
EP01997073A EP1364004A4 (fr) 2000-12-12 2001-12-12 Administration d'une sequence d'acides amines a un animal femelle
AU2002248194A AU2002248194B2 (en) 2000-12-12 2001-12-12 Administration of nucleic acid sequence to female animal
BR0116472-4A BR0116472A (pt) 2000-12-12 2001-12-12 Administração de sequência de ácido nucléico a animal fêmea para aumentar o crescimento de prole

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25502100P 2000-12-12 2000-12-12
US60/255,021 2000-12-12

Publications (3)

Publication Number Publication Date
WO2002061037A2 WO2002061037A2 (fr) 2002-08-08
WO2002061037A3 WO2002061037A3 (fr) 2003-10-02
WO2002061037B1 true WO2002061037B1 (fr) 2004-01-15

Family

ID=22966509

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/048726 WO2002061037A2 (fr) 2000-12-12 2001-12-12 Administration d'une sequence d'acides amines a un animal femelle

Country Status (10)

Country Link
EP (1) EP1364004A4 (fr)
KR (1) KR20040039187A (fr)
CN (1) CN1575301A (fr)
AR (1) AR035671A1 (fr)
AU (1) AU2002248194B2 (fr)
BR (1) BR0116472A (fr)
CA (1) CA2430921C (fr)
MX (1) MXPA03005236A (fr)
PL (1) PL366116A1 (fr)
WO (1) WO2002061037A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003038112A2 (fr) 2001-10-26 2003-05-08 Baylor College Of Medicine Composition et methode permettant de modifier la masse maigre et les proprietes osseuses d'un sujet
MXPA04007638A (es) 2002-02-07 2004-12-06 Baylor College Medicine Desarrollo modificado de la glandula pituitaria en productos de madres animales prenadas, tratadas con terapia de hormona liberadora de hormona del crecimiento.
AU2003249208B2 (en) 2002-07-16 2010-03-04 Vgx Pharmaceuticals, Llc Codon optimized synthetic plasmids
DE10240418A1 (de) * 2002-09-02 2004-03-11 Avontec Gmbh Formulierung zur Einschleusung von Nukleinsäuren in eukaryotische Zellen
AU2003295366B2 (en) * 2002-11-04 2011-11-24 Advisys, Inc. Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells
US20040204358A1 (en) * 2003-01-28 2004-10-14 Advisys, Inc. Reducing culling in herd animals growth hormone releasing hormone (GHRH)
CN102127545A (zh) * 2010-11-24 2011-07-20 山东农业大学 一种骨骼肌特异性ckm启动子及其应用
CN104031930B (zh) * 2014-05-30 2017-09-22 华南农业大学 一种提高母猪乳中营养及免疫物质含量的方法
CN105219774B (zh) * 2015-10-10 2019-04-30 广西大学 猪胰岛素特异性表达启动子pip2及其应用
CN105617404A (zh) * 2016-01-27 2016-06-01 广州市科虎生物技术研究开发中心 Grf表达质粒在制备降低仔猪出生弱仔率的药物中的用途
DE202018105142U1 (de) * 2018-04-29 2018-10-08 Kalmarna Limited - CCS Trustees Limited Zusammensetzungen zur oralen Verabreichung zum Beeinflussen der Nachkommenschaft von Säugetieren

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2622455B1 (fr) * 1987-11-04 1991-07-12 Agronomique Inst Nat Rech Application du facteur de stimulation de la secretion de l'hormone de croissance humaine, de ses fragments actifs et des analogues correspondants, pour augmenter la production laitiere et le poids des nouveau-nes chez les mammiferes
ZA914983B (en) * 1990-06-29 1992-03-25 Hoffmann La Roche His-grf-analogs
US6165755A (en) * 1997-01-23 2000-12-26 University Of Victoria Innovation And Development Corporation Chicken neuropeptide gene useful for improved poultry production
AU8589998A (en) * 1997-07-24 1999-02-16 Valentis, Inc. Ghrh expression system and methods of use
EP1204321B1 (fr) * 1999-07-26 2005-11-09 Baylor College Of Medicine Analogue superactif de la somatostatine porcine

Also Published As

Publication number Publication date
EP1364004A4 (fr) 2005-11-09
AU2002248194B2 (en) 2007-04-05
PL366116A1 (en) 2005-01-24
WO2002061037A2 (fr) 2002-08-08
EP1364004A2 (fr) 2003-11-26
BR0116472A (pt) 2005-04-05
AR035671A1 (es) 2004-06-23
CN1575301A (zh) 2005-02-02
CA2430921C (fr) 2016-06-07
MXPA03005236A (es) 2005-04-08
WO2002061037A3 (fr) 2003-10-02
KR20040039187A (ko) 2004-05-10
CA2430921A1 (fr) 2002-08-08

Similar Documents

Publication Publication Date Title
CN102399283B (zh) 水貂生长激素释放激素cDNA及其应用
WO2002061037B1 (fr) Administration d'une sequence d'acides amines a un animal femelle
CA2378943A1 (fr) Analogue superactif de la somatostatine porcine
IL112403A (en) A method for producing mature growth hormone from cattle at the end of which amine alanine in E.COLI
US20230357345A1 (en) Glycoprotein Hormone Long-Acting Superagonists
CN102399284A (zh) 狐狸生长激素释放激素cDNA及其应用
Lucero et al. ERcalcistorin/protein disulfide isomerase (PDI). Sequence determination and expression of a cDNA clone encoding a calcium storage protein with PDI activity from endoplasmic reticulum of the sea urchin egg.
Mao et al. Ontogeny of growth hormone receptor gene expression in tissue of growth-selected strains of broiler chickens
CA2513743A1 (fr) Reduction de reforme dans l'hormone de croissance (ghrh) d'animaux de troupeau
Khan et al. Effects of maternal plasmid GHRH treatment on offspring growth
US6486134B2 (en) Gene treatment to enhance feed efficiency and growth rate of livestock
CN110819581B (zh) 一种提高动物繁殖力的amh-gnih双表达dna疫苗及其构建方法与应用
EP1686179A1 (fr) Moyens et méthodes pour améliorer le développement et la maturation d'oocytes ou de spermes de poisson utilisant des hormones produites par ces cellules transplantées
US5141922A (en) Biologically active proteins and a method for their use
Bhattacharya et al. Biotechnology input in fish breeding
Singh et al. Insulin-like growth factor I and II gene expression in Balb/C mouse liver during postnatal development
Dunaiski et al. Effect of growth hormone administration on IGF binding protein-3 mRNA levels in porcine tissues
CN104789514B (zh) 一种生长抑制素超表达dna疫苗及构建方法和应用
Etherton Emerging strategies for enhancing growth: is there a biotechnology better than somatotropin?
Duittoz et al. The horse: an unexpected animal model for (unexpected) neuroendocrinology
Armstrong et al. The application of biotechnology for future livestock production
JPS63500941A (ja) 選択的脱アミノ化による哺乳動物ソマトトロピンの生物学的活性の増強
Dai et al. Simultaneous expression of growth hormone releasing hormone (GHRH) and hepatitis B surface antigen/somatostatin (HBsAg/SS) fusion genes in a construct in the skeletal muscle enhances rabbit weight gain
SHORT MRC Unit of Reproductive Biology, Edinburgh
Hansel Prospective developments in animal agriculture

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 01822008.8

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2430921

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1020037007872

Country of ref document: KR

Ref document number: PA/a/2003/005236

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2002248194

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 526621

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2001997073

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 1-2003-500503

Country of ref document: PH

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001997073

Country of ref document: EP

B Later publication of amended claims

Effective date: 20031013

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWP Wipo information: published in national office

Ref document number: 1020037007872

Country of ref document: KR

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: JP

WWG Wipo information: grant in national office

Ref document number: 2002248194

Country of ref document: AU